A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors by Aurora Norman, Mahesh Seetharam, Jacob Allred, Jianping Kong, Mateusz Opyrchal, Wen Wee Ma, Yanyan Lou, Grace K. Dy, Amit Mahipal, S. John Weroha, Andrea E. Wahner Hendrickson, Joel M. Reid, Alex A. Adjei

Get full text

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity by Rachel M. Hurley, Jill M. Wagner, Arun Kanakkanthara, Annapoorna Venkatachalam, Aaron M. Deisinger, Cristina Correia, Paula A. Schneider, Kevin L. Peterson, Elaine P. Macon, Ethan P. Heinzen, Kumar Sanjiv, Xiaonan Hou, Marc A. Becker, Matthew J. Maurer, Melissa C. Larson, Elizabeth M. Swisher, Hu Li, Ann L. Oberg, S. John Weroha, Ulrika Warpman Berglund, Thomas Helleday, Scott H. Kaufmann, Andrea E. Wahner Hendrickson

Get full text